Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxymethyl)-naphthalen-2-yl-methyl]-ammonium chloride combined with at least one glucocorticodortic for use in the treatment of muscular dystrophy

AL13566BActive Publication Date: 2026-07-01ITALFARMACO SPA
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
AL · AL
Patent Type
Patents
Current Assignee / Owner
ITALFARMACO SPA
Filing Date
2026-04-27
Publication Date
2026-07-01
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.